United States Biotechnology & Medical Research

Traws Pharma Inc (TRAW)

Track

Traws Pharma Inc. recorded its most recent insider activity on April 16, 2026, involving a significant purchase by OrbiMed Advisors LLC. Prior to this event, historical records indicate various proposed sales and planned acquisitions by company officers. No trading occurred within the last three months, reflecting a period of inactivity regarding internal equity movements.
Ticker: TRAW Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Traws Pharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 16 Apr 2026
Value US$1,495,249.66 | Price 439.47 | Shares 69,557 (+3.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-28 2026-04-16 B Purchase
2.6
ORBIMED ADVISORS LLC
Large shareholder
69,557 +3.4%
439.47
US$1,495,250 		69,557 +3.4% 439.47 US$1,495,250
2024-03-14 2024-03-14 PrS Proposed sale
3.8
MARK GUERIN

Officer

Officer
54,868
89.65
US$724,304 		54,868 89.65 US$724,304
2024-03-14 2024-03-14 PrS Proposed sale
3.6
STEVEN M FRUCHTMAN

Officer; Director

Executive Director
24,815
489.34
US$1,318,311 		24,815 489.34 US$1,318,311
2024-02-08 2024-02-08 PrS Proposed sale
3.6
STEVEN M FRUCHTMAN

Officer; Director

Executive Director
9,212
0.67
US$6,173 		9,212 0.67 US$6,173
2022-01-31 2022-01-28 PP Planned purchase
3.8
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
1,500 +6.5%
1.67
US$2,505 		1,500 +6.5% 1.67 US$2,505
2022-01-24 2022-01-21 PP Planned purchase
3.8
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
1,500 +7.0%
2.02
US$3,030 		1,500 +7.0% 2.02 US$3,030
2022-01-18 2022-01-14 PP Planned purchase
3.8
OLER ABRAHAM N.

SVP CORP DEV & GEN COUNSEL

Officer
1,500 +7.5%
2.20
US$3,300 		1,500 +7.5% 2.20 US$3,300
2022-01-10 2022-01-07 PP Planned purchase
3.8
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
1,500 +8.1%
2.39
US$3,585 		1,500 +8.1% 2.39 US$3,585
2021-11-23 2021-11-19 B Purchase
3.8
OLER ABRAHAM N.

SVP CORP DEV & GEN COUNSEL

Officer
1,000 +5.7%
3.16
US$3,160 		1,000 +5.7% 3.16 US$3,160
2021-09-29 2021-09-28 B Purchase
3.8
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
2,381 +23.5%
4.20
US$10,000 		2,381 +23.5% 4.20 US$10,000
2021-09-29 2021-09-28 B Purchase
Gelder Mark S. MD

Chief Medical Officer

Officer
2,381 +inf%
4.20
US$10,000 		2,381 +inf% 4.20 US$10,000
2021-09-28 2021-09-28 B Purchase
3.8
MARINO JAMES J
Non-Executive Director
5,952 +38.7%
4.20
US$24,998 		5,952 +38.7% 4.20 US$24,998
2021-09-28 2021-09-28 B Purchase
3.6
Fruchtman Steven M

President, Chief Executive Off

Executive Director
2,381 +15.1%
4.20
US$10,000 		2,381 +15.1% 4.20 US$10,000
2021-02-17 2021-02-16 B Purchase
3.8
MARINO JAMES J
Non-Executive Director
25,000 +12.2%
1.00
US$25,000 		25,000 +12.2% 1.00 US$25,000
2021-02-17 2021-02-16 B Purchase
3.8
Guerin Mark Patrick

Chief Financial Officer

Officer
15,000 +11.5%
1.00
US$15,000 		15,000 +11.5% 1.00 US$15,000
2021-02-17 2021-02-16 B Purchase
3.6
Fruchtman Steven M

President, Chief Executive Off

Executive Director
20,000 +9.2%
1.00
US$20,000 		20,000 +9.2% 1.00 US$20,000
2021-02-17 2021-02-16 B Purchase
3.8
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
12,000 +8.6%
1.00
US$12,000 		12,000 +8.6% 1.00 US$12,000
2021-02-17 2021-02-16 B Purchase
3.4
Shoemaker Mary Teresa
Non-Executive Director
13,000 +34.5%
1.00
US$13,000 		13,000 +34.5% 1.00 US$13,000
2020-12-14 2020-12-11 B Purchase
3.8
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
30,000 +27.3%
0.32
US$9,600 		30,000 +27.3% 0.32 US$9,600
2020-11-30 2020-11-27 B Purchase
3.8
Guerin Mark Patrick

Chief Financial Officer

Officer
4,614 +3.7%
0.26
US$1,200 		4,614 +3.7% 0.26 US$1,200
2020-11-30 2020-11-25 B Purchase
3.4
Shoemaker Mary Teresa
Non-Executive Director
37,735 +inf%
0.27
US$10,000 		37,735 +inf% 0.27 US$10,000
2020-11-30 2020-11-25 B Purchase
3.8
Guerin Mark Patrick

Chief Financial Officer

Officer
16,755 +15.4%
0.26
US$4,356 		16,755 +15.4% 0.26 US$4,356
2020-11-30 2020-11-25 B Purchase
3.8
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
20,000 +22.2%
0.26
US$5,120 		20,000 +22.2% 0.26 US$5,120
2020-11-30 2020-11-25 B Purchase
3.6
Fruchtman Steven M

President, Chief Executive Off

Executive Director
40,000 +22.7%
0.26
US$10,360 		40,000 +22.7% 0.26 US$10,360
2020-11-27 2020-11-24 B Purchase
3.8
MARINO JAMES J
Non-Executive Director
38,774 +23.2%
0.26
US$10,004 		38,774 +23.2% 0.26 US$10,004
2020-08-31 2020-08-27 S Sale
3.6
Hoffman Michael B
Non-Executive Director
1,876 -100.0%
0.27
US$510 		1,876 -100.0% 0.27 US$510
2020-08-31 2020-08-27 S Sale
1.4
Reddy E Premkumar
Non-Executive Director
527,863 -96.9%
0.27
US$143,948 		527,863 -96.9% 0.27 US$143,948
2020-08-31 2020-08-27 S Sale
3.6
Hoffman Michael B
Non-Executive Director
182,492 -89.3%
0.27
US$49,620 		182,492 -89.3% 0.27 US$49,620
2020-05-21 2020-05-19 B Purchase
2.5
GROOPMAN JEROME
Non-Executive Director
10,000 +1000000.0%
0.36
US$3,626 		10,000 +1000000.0% 0.36 US$3,626
2020-05-20 2020-05-19 B Purchase
3.6
Fruchtman Steven M

President, Chief Executive Off

Executive Director
26,800 +17.9%
0.37
US$9,857 		26,800 +17.9% 0.37 US$9,857
2020-05-20 2020-05-19 B Purchase
3.8
Guerin Mark Patrick

Chief Financial Officer

Officer
21,000 +23.9%
0.36
US$7,560 		21,000 +23.9% 0.36 US$7,560
2020-05-20 2020-05-19 B Purchase
3.8
OLER ABRAHAM N.

SVP Corp Dev & Gen Counsel

Officer
15,000 +20.0%
0.37
US$5,550 		15,000 +20.0% 0.37 US$5,550
2019-11-27 2019-11-25 B Purchase
MEHTA VIREN
250,000 +29171.5%
0.20
US$50,000 		250,000 +29171.5% 0.20 US$50,000
2019-11-26 2019-11-25 B Purchase OLER ABRAHAM N.

VP Corp Dev & Gen Counsel

Officer
75,000 +inf%
0.20
US$15,000 		75,000 +inf% 0.20 US$15,000
2019-11-26 2019-11-25 B Purchase Guerin Mark Patrick

Chief Financial Officer

Officer
87,500 +25436.0%
0.20
US$17,500 		87,500 +25436.0% 0.20 US$17,500
2019-11-26 2019-11-25 B Purchase MARINO JAMES J Non-Executive Director
150,000 +885.4%
0.20
US$30,000 		150,000 +885.4% 0.20 US$30,000
2019-11-26 2019-11-25 B Purchase Fruchtman Steven M

President, Chief Executive Off

Executive Director
149,000 +34976.5%
0.20
US$29,800 		149,000 +34976.5% 0.20 US$29,800
2019-11-26 2019-11-25 B Purchase Reddy E Premkumar Non-Executive Director
500,000 +1122.4%
0.20
US$100,000 		500,000 +1122.4% 0.20 US$100,000
2019-09-26 2019-09-25 B Purchase
3.8
MARINO JAMES J
7,260 +75.0%
1.60
US$11,616 		7,260 +75.0% 1.60 US$11,616
2019-09-26 2019-09-24 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
16,700 -2.6%
1.19
US$19,873 		16,700 -2.6% 1.19 US$19,873
2019-09-25 2019-09-23 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2019-09-25 2019-09-23 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
10,249 -1.2%
1.27
US$13,016 		10,249 -1.2% 1.27 US$13,016
2019-09-24 2019-09-23 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
37,242 -5.6%
1.23
US$45,968 		37,242 -5.6% 1.23 US$45,968
2019-09-24 2019-09-20 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
75,119 -10.1%
1.62
US$121,430 		75,119 -10.1% 1.62 US$121,430
2019-09-20 2019-09-18 S Sale
3.4
683 Capital Management, LLC
1,533 -0.3%
2.20
US$3,376 		1,533 -0.3% 2.20 US$3,376
2019-09-20 2019-09-18 S Sale
3.4
683 Capital Management, LLC
120,000 -20.6%
1.82
US$218,184 		120,000 -20.6% 1.82 US$218,184
2019-09-20 2019-09-18 S Sale
3.4
683 Capital Management, LLC
173,332 -23.0%
2.18
US$377,448 		173,332 -23.0% 2.18 US$377,448
2019-09-20 2019-09-18 S Sale
3.4
683 Capital Management, LLC
93,286 -11.0%
1.86
US$173,139 		93,286 -11.0% 1.86 US$173,139
2019-09-20 2019-09-18 S Sale
3.4
683 Capital Management, LLC
118,726 -12.3%
2.18
US$258,538 		118,726 -12.3% 2.18 US$258,538
2019-09-20 2019-09-18 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
49,995 -6.3%
2.10
US$105,014 		49,995 -6.3% 2.10 US$105,014
2019-09-13 2019-09-11 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
1,247 -0.2%
2.75
US$3,432 		1,247 -0.2% 2.75 US$3,432
2019-09-11 2019-09-09 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
400 -0.1%
2.77
US$1,106 		400 -0.1% 2.77 US$1,106
2019-09-09 2019-09-06 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
5,015 -0.6%
2.78
US$13,954 		5,015 -0.6% 2.78 US$13,954
2019-09-09 2019-09-05 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
400 -0.0%
2.75
US$1,100 		400 -0.0% 2.75 US$1,100
2019-07-11 2019-07-10 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
2,742 -0.3%
2.81
US$7,697 		2,742 -0.3% 2.81 US$7,697
2019-07-11 2019-07-09 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
8,185 -1.0%
2.84
US$23,204 		8,185 -1.0% 2.84 US$23,204
2019-07-01 2019-06-27 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
1,458 -0.2%
3.45
US$5,025 		1,458 -0.2% 3.45 US$5,025
2019-06-27 2019-06-25 S Sale
4.1
TYNDALL CAPITAL PARTNERS L P
Large shareholder
1,380 -0.2%
3.40
US$4,689 		1,380 -0.2% 3.40 US$4,689
2018-08-29 2018-08-29 S Sale Hoffman Michael B Non-Executive Director
29,999 -0.5%
0.45
US$13,521 		29,999 -0.5% 0.45 US$13,521
2018-08-29 2018-08-28 S Sale Hoffman Michael B Non-Executive Director
30,000 -0.5%
0.46
US$13,707 		30,000 -0.5% 0.46 US$13,707
2018-08-29 2018-08-28 S Sale Hoffman Michael B Non-Executive Director
20,000 -0.3%
0.44
US$8,890 		20,000 -0.3% 0.44 US$8,890
2018-08-29 2018-08-27 S Sale Hoffman Michael B Non-Executive Director
20,000 -0.3%
0.45
US$9,070 		20,000 -0.3% 0.45 US$9,070
2018-05-01 2018-04-27 B Purchase Reddy E Premkumar Non-Executive Director
282,350
0.00
US$0 		282,350 0.00 US$0
2018-05-01 2018-04-27 B Purchase MARINO JAMES J Non-Executive Director
58,900
0.00
US$0 		58,900 0.00 US$0
2018-05-01 2018-04-27 B Purchase 683 Capital Management, LLC Large shareholder
11,838,235 +444.2%
0.43
US$5,031,250 		11,838,235 +444.2% 0.43 US$5,031,250
2018-05-01 2018-04-27 B Purchase TYNDALL CAPITAL PARTNERS L P Large shareholder
10,147,058 +483.9%
0.43
US$4,312,500 		10,147,058 +483.9% 0.43 US$4,312,500
2018-05-01 2018-04-27 B Purchase Hoffman Michael B Non-Executive Director
2,211,765
0.00
US$0 		2,211,765 0.00 US$0
2018-05-01 2018-04-27 B Purchase STOVER JACK E Non-Executive Director
47,100
0.00
US$0 		47,100 0.00 US$0
2018-02-12 2018-02-08 B Purchase MARINO JAMES J Non-Executive Director
50,000
0.00
US$0 		50,000 0.00 US$0
2018-02-12 2018-02-08 B Purchase 683 Capital Management, LLC Large shareholder
200,000 +8.1%
1.04
US$207,120 		200,000 +8.1% 1.04 US$207,120
2018-02-12 2018-02-08 B Purchase TYNDALL CAPITAL PARTNERS L P Large shareholder
1,100,000 +110.3%
1.01
US$1,111,000 		1,100,000 +110.3% 1.01 US$1,111,000
2017-04-28 2017-04-26 B Purchase Bienen Henry S
3,810 +42.7%
2.10
US$8,001 		3,810 +42.7% 2.10 US$8,001
2017-04-28 2017-04-26 B Purchase MARINO JAMES J
11,906 +48.8%
2.10
US$25,003 		11,906 +48.8% 2.10 US$25,003
2017-04-28 2017-04-26 B Purchase Kumar Ramesh

President and CEO

Executive Director
23,810 +30.4%
2.10
US$50,001 		23,810 +30.4% 2.10 US$50,001
2017-04-28 2017-04-26 B Purchase Reddy E Premkumar
119,048 +44.6%
2.10
US$250,001 		119,048 +44.6% 2.10 US$250,001
Explore more

More insider trading research around Traws Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America